InvestorsHub Logo
Followers 6
Posts 1400
Boards Moderated 0
Alias Born 08/24/2014

Re: dr_lowenstein post# 44487

Saturday, 04/28/2018 8:24:02 PM

Saturday, April 28, 2018 8:24:02 PM

Post# of 48316
Solid data in the PISCES trial for Oncosec will solidify an FDA approval and that will validate their science and vindicate management. Only looking better and better for Oncosec this year. Preliminary data for TNBC looks promising too, so Big Pharma has something else to think about, not just melanoma when considereing the prospects for Oncosec. A share price spike on solid PISCES data this year may have ONCS running like CPXX right into a buyout.